Hot Features
Invion Limited, a clinical-stage life sciences company, researches and develops Photosoft technology for the treatment of cancers, atherosclerosis, and infectious diseases in Australia. The company develops IVX-PDT, a photosensitising agent to treat a range of cancers, such as skin, prostate, ano-ge... Invion Limited, a clinical-stage life sciences company, researches and develops Photosoft technology for the treatment of cancers, atherosclerosis, and infectious diseases in Australia. The company develops IVX-PDT, a photosensitising agent to treat a range of cancers, such as skin, prostate, ano-genital, glioblastoma multiforme, lung, and ovarian cancers; and human papilloma virus. It is also involved in the development of INV043, which is in Phase II clinical trial for the treatment of patients with prostate cancer; and in Phase I/II clinical trial to treat non-melanoma skin cancer, as well as for the treatment of oesophageal cancer. The company has collaborations with Hudson Institute of Medical Research, Peter MacCallum Cancer Centre, Dr. I&B Co., Ltd., and Hanlim Pharm Co., Ltd. Invion Limited was incorporated in 2000 and is headquartered in Melbourne, Australia. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.003 | -6.97674418605 | 0.043 | 0.045 | 0.04 | 73306 | 0.04100003 | DE |
| 4 | -0.01 | -20 | 0.05 | 0.05 | 0.035 | 101295 | 0.04506396 | DE |
| 12 | -0.03 | -42.8571428571 | 0.07 | 0.072 | 0.035 | 207927 | 0.05490041 | DE |
| 26 | -0.051 | -56.043956044 | 0.091 | 0.099 | 0.035 | 138086 | 0.06317227 | DE |
| 52 | -0.08 | -66.6666666667 | 0.12 | 0.2 | 0.035 | 128461 | 0.08436496 | DE |
| 156 | 0.035 | 700 | 0.005 | 0.43 | 0.002 | 1058692 | 0.01052121 | DE |
| 260 | 0.025 | 166.666666667 | 0.015 | 0.43 | 0.002 | 2714268 | 0.01807623 | DE |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.